COVID-19 rapid test G86250
immunityfor neutralizing antibodyblood

COVID-19 rapid test - G86250 - Shenzhen Yhlo Biotech Co., Ltd. - immunity / for neutralizing antibody / blood
COVID-19 rapid test - G86250 - Shenzhen Yhlo Biotech Co., Ltd. - immunity / for neutralizing antibody / blood
Add to favorites
Compare this product
 

Characteristics

Applications
COVID-19
Application field
immunity
Tested parameter
for neutralizing antibody
Sample type
blood, serum, plasma, whole blood, clinical
Analysis mode
immunoassay
Result display time

15 min

Description

GLINE-2019-nCoV NAb (Neutralization Antibody) Test is a colloidal gold immunoassay (CGIA) for qualitative determination of the Neutralization antibodies from whole blood, serum or plasma. This assay can detect neutralization antibodies in patients recovering from COVID-19 or vaccination. Features: ●Simple to use, affordable, and self-administered ●Compatible with serum, plasma, whole blood and fingertip blood ●Can be scaled for frequent screening of personal health and population health. Clinical Benefits: ●Evaluate COVID-19 vaccines development and efficacy ●Monitor the Neutralization Antibody titers in COVID-19 patients and vaccinated individuals ●Analyze herd immunity status to guide policymakers ●Monitor during convalescent plasma therapy or other antibody related treatments

Catalogs

No catalogs are available for this product.

See all of Shenzhen Yhlo Biotech Co., Ltd.‘s catalogs
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.